Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...

Male Sexual Response: Erection & Ejaculation

Male Sexual Response: Erection & Ejaculation

Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Self-Assembled Nanoparticles of Licorice Extract Enhance Skin Penetration and Regulate Barrier Proteins via a Dual-Channel Pathway.

Pharmaceutics·2026

Same author

Readability of sexual health educational materials: a comparative analysis of ISSM resources and large language model-generated content.

The journal of sexual medicine·2026

Same author

Development and validation of a clinical practice guidelines implementability assessment tool (CPG-IAT) based on the COSMIN framework.

Implementation science : IS·2026

Same author

Myocardial Temporal-Mechanical Self-Supervision Model for Contrast-Free Myocardial Infarction Segmentation with Label-Free Training.

IEEE transactions on medical imaging·2026

Same author

Multicolor room-temperature phosphorescence induced by aggregation and TS-FRET in carbon dot composites.

Nanoscale·2026

Same author

A comparative evaluation of on-demand phosphodiesterase-5 inhibitor efficacy in erectile dysfunction treatment: a systematic review and network meta-analysis of double-blind, placebo-controlled, randomized trials.

The journal of sexual medicine·2026

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Combination therapy for erectile dysfunction: an update review.

Rohit R Dhir¹, Hao-Cheng Lin, Steven E Canfield

¹Division of Urology, University of Texas Medical School at Houston, Houston, TX 77030, USA.

Asian Journal of Andrology

|March 23, 2011

Summary

This summary is machine-generated.

Combination therapies show promise for erectile dysfunction (ED) patients unresponsive to phosphodiesterase-5 inhibitors (PDE5Is). Further research is needed to overcome study limitations and establish optimal treatment strategies for complex ED cases.

Related Experiment Videos

Last Updated: Jun 3, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Area of Science:

Sexual Medicine
Urology

Background:

Oral phosphodiesterase-5 inhibitors (PDE5Is) are first-line therapy for erectile dysfunction (ED).
A significant number of patients with complex ED do not respond to PDE5I monotherapy.
Combination therapy is increasingly used for refractory ED, but lacks critical evaluation.

Purpose of the Study:

To critically evaluate the effectiveness of combination therapies for ED in patients non-responsive to PDE5I monotherapy.
To review existing literature on PDE5I-based combination treatments for complex ED.

Main Methods:

A comprehensive literature search of PubMed and Cochrane Library was performed.
Articles published between January 1990 and December 2010 were reviewed, including reviews, RCTs, cohort, and retrospective studies.
References from retrieved articles were manually scanned for additional relevant publications.

Main Results:

Various combination therapies were identified, including PDE5I with vacuum erectile devices (VED), intraurenal medication, intracavernosal injection (ICI), androgen supplements, and alpha-blockers.
Some combination treatments demonstrated effectiveness in preliminary studies.
The majority of studies had limitations, such as small sample sizes and study biases.

Conclusions:

Combination therapies offer potential for managing complex ED cases refractory to PDE5Is.
Current research provides a foundation for future studies, but methodological improvements are necessary.
Further high-quality research is required to establish evidence-based guidelines for combination therapy in ED.